United States Biotechnology & Medical Research

Entrada Therapeutics, Inc. (TRDA)

Track

Track

Entrada Therapeutics Inc. experienced significant selling activity over the past ninety days, totaling approximately 14.66 million dollars. MPM BioVentures entities executed thirty-six divestments, reflecting a consistent reduction in holdings. This pattern follows the most recent earnings report, which showed a 12.93 percent beat, while the stock price remains near its yearly lows.
Ticker: TRDA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Entrada Therapeutics, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
4.0
PARMAR KUSH Non-Executive Director
Transaction date
Sale
Price
7.00
Quantity 92,444 -3.3%
Value US$647,108
4.0
PARMAR KUSH Non-Executive Director
Transaction date
Sale
Price
6.85
Quantity 52,317 -1.8%
Value US$358,371
3.5
5AM Ventures V, L.P. Large shareholder
Transaction date
Sale
Price
6.85
Quantity 52,317 -1.8%
Value US$358,371
4.0
PARMAR KUSH Non-Executive Director
Transaction date
Sale
Price
7.00
Quantity 10,494 -0.4%
Value US$73,458
3.5
5AM Ventures V, L.P. Large shareholder
Transaction date
Sale
Price
7.00
Quantity 10,494 -0.4%
Value US$73,458
3.5
5AM Ventures V, L.P. Large shareholder
Transaction date
Sale
Price
6.85
Quantity 1,718 -0.1%
Value US$11,768
4.0
PARMAR KUSH Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.85
Quantity 1,718 -0.1%
Value US$11,768
3.5
5AM Ventures V, L.P. Affiliated stockholder Large shareholder
Transaction date
Proposed sale
Price
6.55
Quantity 165,578
Value US$1,084,536
3.5
5AM Ventures V, L.P. Affiliated stockholder Large shareholder
Transaction date
Proposed sale
Price
6.55
Quantity 165,578
Value US$1,084,536
3.5
5AM Ventures V, L.P. Large shareholder
Transaction date
Sale
Price
6.93
Quantity 114,756 -3.9%
Value US$795,259
4.0
PARMAR KUSH Non-Executive Director Large shareholder
Transaction date
Sale
Price
6.93
Quantity 114,756 -3.9%
Value US$795,259
3.5
5AM Ventures V, L.P. Affiliated stockholder Large shareholder
Transaction date
Proposed sale
Price
6.55
Quantity 331,156
Value US$2,169,072
3.8
Zeiher Bernhardt G Non-Executive Director
Transaction date
Purchase
Price
5.86
Quantity 5,000 +inf%
Value US$29,316
Sethuraman Natarajan President, Research & Develop. Officer
Transaction date
Planned sale
Price
15.39
Quantity 25,907 -10.7%
Value US$398,810
Dowden Nathan J President & COO Officer
Transaction date
Planned sale
Price
15.33
Quantity 15,000 -7.0%
Value US$229,953
NATHAN DOWDEN Officer Officer
Transaction date
Proposed sale
Price
14.50
Quantity 15,000
Value US$217,500
NATARAJAN SETHURAMAN Officer Officer
Transaction date
Proposed sale
Price
14.50
Quantity 25,907
Value US$375,652
3.4
WENTWORTH KORY JAMES Chief Financial Officer Officer
Transaction date
Planned sale
Price
12.95
Quantity 2,500 -2.1%
Value US$32,375
3.4
KORY WENTWORTH Officer Officer
Transaction date
Proposed sale
Price
12.62
Quantity 2,500
Value US$31,550
Dowden Nathan J President & COO Officer
Transaction date
Planned sale
Price
13.05
Quantity 11,894 -5.7%
Value US$155,188
3.4
WENTWORTH KORY JAMES Chief Financial Officer Officer
Transaction date
Planned sale
Price
13.02
Quantity 11,388 -8.6%
Value US$148,216
Dowden Nathan J President & COO Officer
Transaction date
Planned sale
Price
13.02
Quantity 3,116 -1.5%
Value US$40,583
3.4
WENTWORTH KORY JAMES Chief Financial Officer Officer
Transaction date
Planned sale
Price
13.00
Quantity 5,089 -3.7%
Value US$66,163
3.4
KORY WENTWORTH Officer Officer
Transaction date
Proposed sale
Price
12.58
Quantity 16,477
Value US$207,281
NATHAN DOWDEN Officer Officer
Transaction date
Proposed sale
Price
12.58
Quantity 15,010
Value US$188,826
3.4
WENTWORTH KORY JAMES Chief Financial Officer Officer
Transaction date
Planned sale
Price
12.25
Quantity 7,988 -5.5%
Value US$97,892
3.4
KORY WENTWORTH Officer Officer
Transaction date
Proposed sale
Price
11.85
Quantity 7,988
Value US$94,658
3.4
WENTWORTH KORY JAMES Chief Financial Officer Officer
Transaction date
Planned sale
Price
9.98
Quantity 8,910 -7.5%
Value US$88,932
3.4
KORY WENTWORTH Officer Officer
Transaction date
Proposed sale
Price
9.17
Quantity 8,910
Value US$81,705
3.4
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
9.07
Quantity 13,082 +0.3%
Value US$118,690
3.4
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
9.07
Quantity 1,186 +0.3%
Value US$10,760
3.4
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
9.07
Quantity 13,386 +0.3%
Value US$121,395
3.4
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
9.07
Quantity 1,213 +0.3%
Value US$11,000
3.5
5AM Ventures V, L.P. Large shareholder
Transaction date
Sale
Price
8.80
Quantity 200,000 -6.3%
Value US$1,760,000
4.0
PARMAR KUSH Non-Executive Director Large shareholder
Transaction date
Sale
Price
8.80
Quantity 200,000 -6.3%
Value US$1,760,000
3.5
5AM Ventures V, L.P. Affiliated Stockholder Large shareholder
Transaction date
Proposed sale
Price
8.80
Quantity 200,000
Value US$1,760,664
3.4
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
7.95
Quantity 11,494 +0.2%
Value US$91,431
3.4
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
7.95
Quantity 1,040 +0.3%
Value US$8,273
3.4
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
7.73
Quantity 80,881 +1.8%
Value US$625,331
3.4
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
7.73
Quantity 7,321 +2.0%
Value US$56,602
3.4
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
7.54
Quantity 30,879 +0.7%
Value US$232,812
3.4
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
7.54
Quantity 2,795 +0.8%
Value US$21,073
3.4
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
7.39
Quantity 11,701 +0.3%
Value US$86,481
3.4
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
7.39
Quantity 1,059 +0.3%
Value US$7,827
3.4
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
7.22
Quantity 2,947 +0.1%
Value US$21,290
3.4
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
7.21
Quantity 25,364 +0.6%
Value US$182,973
3.4
BAKER BROS. ADVISORS LP Large shareholder
Transaction date
Purchase
Price
7.21
Quantity 2,296 +0.6%
Value US$16,563
3.5
5AM Ventures V, L.P. Large shareholder
Transaction date
Sale
Price
7.50
Quantity 6,935 -0.6%
Value US$52,026
3.5
5AM Ventures V, L.P. Large shareholder
Transaction date
Sale
Price
7.50
Quantity 20,065 -0.6%
Value US$150,528
4.0
PARMAR KUSH Non-Executive Director Large shareholder
Transaction date
Sale
Price
7.50
Quantity 6,935 -0.6%
Value US$52,026
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-09 2026-09-09 S Sale
3.2
MPM BIOVENTURES 2018, L.P.
Large shareholder
3,568 -38.0%
202.09
US$3,496,927 		3,568 -38.0% 202.09 US$3,496,927
2026-09-09 2026-09-09 S Sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
48,991 +3.7%
420.11
US$2,993,444 		48,991 +3.7% 420.11 US$2,993,444
2026-09-09 2026-09-08 S Sale
3.2
MPM BIOVENTURES 2018, L.P.
Large shareholder
6,397 -1.3%
125.27
US$3,806,147 		6,397 -1.3% 125.27 US$3,806,147
2026-09-09 2026-09-08 S Sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
1,000 -4.7%
7.41
US$100,000 		1,000 -4.7% 7.41 US$100,000
2026-09-09 2026-09-04 S Sale
3.2
MPM BIOVENTURES 2018, L.P.
Large shareholder
1,000 -0.9%
7.11
US$100,000 		1,000 -0.9% 7.11 US$100,000
2026-09-09 2026-09-04 S Sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
1,000 -0.9%
7.11
US$100,000 		1,000 -0.9% 7.11 US$100,000
2026-09-03 2026-09-03 S Sale
3.2
MPM BIOVENTURES 2018, L.P.
Large shareholder
32,263 -0.8%
7.17
US$231,326 		32,263 -0.8% 7.17 US$231,326
2026-09-03 2026-09-03 S Sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
32,263 -0.8%
7.17
US$231,326 		32,263 -0.8% 7.17 US$231,326
2026-09-03 2026-09-02 S Sale
3.2
MPM BIOVENTURES 2018, L.P.
Large shareholder
25,131 -0.6%
7.19
US$180,692 		25,131 -0.6% 7.19 US$180,692
2026-09-03 2026-09-02 S Sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
25,131 -0.6%
7.19
US$180,692 		25,131 -0.6% 7.19 US$180,692
2026-09-03 2026-09-01 S Sale
3.2
MPM BIOVENTURES 2018, L.P.
Large shareholder
29,088 -0.7%
7.06
US$205,361 		29,088 -0.7% 7.06 US$205,361
2026-09-03 2026-09-01 S Sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
29,088 -0.7%
7.06
US$205,361 		29,088 -0.7% 7.06 US$205,361
2026-08-31 2026-08-31 S Sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
44,259 -1.0%
6.99
US$309,370 		44,259 -1.0% 6.99 US$309,370
2026-08-31 2026-08-31 S Sale
3.2
MPM BIOVENTURES 2018, L.P.
Large shareholder
44,259 -1.0%
6.99
US$309,370 		44,259 -1.0% 6.99 US$309,370
2026-08-31 2026-08-28 S Sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
3,733 -0.1%
7.01
US$26,168 		3,733 -0.1% 7.01 US$26,168
2026-08-31 2026-08-28 S Sale
3.2
MPM BIOVENTURES 2018, L.P.
Large shareholder
3,733 -0.1%
7.01
US$26,168 		3,733 -0.1% 7.01 US$26,168
2026-08-31 2026-08-27 S Sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
38,922 -0.9%
7.20
US$280,238 		38,922 -0.9% 7.20 US$280,238
2026-08-31 2026-08-27 S Sale
3.2
MPM BIOVENTURES 2018, L.P.
Large shareholder
38,922 -0.9%
7.20
US$280,238 		38,922 -0.9% 7.20 US$280,238
2026-08-26 2026-08-26 S Sale
3.2
MPM BIOVENTURES 2018, L.P.
Large shareholder
14,569 -0.3%
7.06
US$102,857 		14,569 -0.3% 7.06 US$102,857
2026-08-26 2026-08-26 S Sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
14,569 -0.3%
7.06
US$102,857 		14,569 -0.3% 7.06 US$102,857
2026-08-26 2026-08-25 S Sale
3.2
MPM BIOVENTURES 2018, L.P.
Large shareholder
26,522 -0.6%
7.54
US$199,976 		26,522 -0.6% 7.54 US$199,976
2026-08-26 2026-08-25 S Sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
26,522 -0.6%
7.54
US$199,976 		26,522 -0.6% 7.54 US$199,976
2026-08-26 2026-08-24 S Sale
3.2
MPM BIOVENTURES 2018, L.P.
Large shareholder
21,623 -0.5%
7.34
US$158,713 		21,623 -0.5% 7.34 US$158,713
2026-08-26 2026-08-24 S Sale
3.2
MPM BioVentures 2014, L.P.
Large shareholder
21,623 -0.5%
7.34
US$158,713 		21,623 -0.5% 7.34 US$158,713
2026-08-10 2026-08-10 S Sale
4.0
PARMAR KUSH
Non-Executive Director
92,444 -3.3%
7.00
US$647,108 		92,444 -3.3% 7.00 US$647,108
2026-08-10 2026-08-07 S Sale
4.0
PARMAR KUSH
Non-Executive Director
52,317 -1.8%
6.85
US$358,371 		52,317 -1.8% 6.85 US$358,371
2026-08-10 2026-08-07 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
52,317 -1.8%
6.85
US$358,371 		52,317 -1.8% 6.85 US$358,371
2026-08-10 2026-08-06 S Sale
4.0
PARMAR KUSH
Non-Executive Director
10,494 -0.4%
7.00
US$73,458 		10,494 -0.4% 7.00 US$73,458
2026-08-10 2026-08-06 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
10,494 -0.4%
7.00
US$73,458 		10,494 -0.4% 7.00 US$73,458
2026-08-03 2026-07-31 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
1,718 -0.1%
6.85
US$11,768 		1,718 -0.1% 6.85 US$11,768
2026-08-03 2026-07-31 S Sale
4.0
PARMAR KUSH
Non-Executive Director Large shareholder
1,718 -0.1%
6.85
US$11,768 		1,718 -0.1% 6.85 US$11,768
2026-08-10 2026-07-30 PrS Proposed sale
3.5
5AM Ventures V, L.P.

Affiliated stockholder

Large shareholder
165,578
6.55
US$1,084,536 		165,578 6.55 US$1,084,536
2026-08-10 2026-07-30 PrS Proposed sale
3.5
5AM Ventures V, L.P.

Affiliated stockholder

Large shareholder
165,578
6.55
US$1,084,536 		165,578 6.55 US$1,084,536
2026-08-03 2026-07-30 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
114,756 -3.9%
6.93
US$795,259 		114,756 -3.9% 6.93 US$795,259
2026-08-03 2026-07-30 S Sale
4.0
PARMAR KUSH
Non-Executive Director Large shareholder
114,756 -3.9%
6.93
US$795,259 		114,756 -3.9% 6.93 US$795,259
2026-07-30 2026-07-30 PrS Proposed sale
3.5
5AM Ventures V, L.P.

Affiliated stockholder

Large shareholder
331,156
6.55
US$2,169,072 		331,156 6.55 US$2,169,072
2026-05-21 2026-05-20 B Purchase
3.8
Zeiher Bernhardt G
Non-Executive Director
5,000 +inf%
5.86
US$29,316 		5,000 +inf% 5.86 US$29,316
2026-05-04 2026-05-04 PlS Planned sale
Sethuraman Natarajan

President, Research & Develop.

Officer
25,907 -10.7%
15.39
US$398,810 		25,907 -10.7% 15.39 US$398,810
2026-05-04 2026-05-04 PlS Planned sale
Dowden Nathan J

President & COO

Officer
15,000 -7.0%
15.33
US$229,953 		15,000 -7.0% 15.33 US$229,953
2026-05-04 2026-05-04 PrS Proposed sale
NATHAN DOWDEN

Officer

Officer
15,000
14.50
US$217,500 		15,000 14.50 US$217,500
2026-05-04 2026-05-04 PrS Proposed sale
NATARAJAN SETHURAMAN

Officer

Officer
25,907
14.50
US$375,652 		25,907 14.50 US$375,652
2026-04-02 2026-04-01 PlS Planned sale
3.4
WENTWORTH KORY JAMES

Chief Financial Officer

Officer
2,500 -2.1%
12.95
US$32,375 		2,500 -2.1% 12.95 US$32,375
2026-04-01 2026-04-01 PrS Proposed sale
3.4
KORY WENTWORTH

Officer

Officer
2,500
12.62
US$31,550 		2,500 12.62 US$31,550
2026-03-11 2026-03-10 PlS Planned sale
Dowden Nathan J

President & COO

Officer
11,894 -5.7%
13.05
US$155,188 		11,894 -5.7% 13.05 US$155,188
2026-03-11 2026-03-10 PlS Planned sale
3.4
WENTWORTH KORY JAMES

Chief Financial Officer

Officer
11,388 -8.6%
13.02
US$148,216 		11,388 -8.6% 13.02 US$148,216
2026-03-11 2026-03-09 PlS Planned sale
Dowden Nathan J

President & COO

Officer
3,116 -1.5%
13.02
US$40,583 		3,116 -1.5% 13.02 US$40,583
2026-03-11 2026-03-09 PlS Planned sale
3.4
WENTWORTH KORY JAMES

Chief Financial Officer

Officer
5,089 -3.7%
13.00
US$66,163 		5,089 -3.7% 13.00 US$66,163
2026-03-09 2026-03-09 PrS Proposed sale
3.4
KORY WENTWORTH

Officer

Officer
16,477
12.58
US$207,281 		16,477 12.58 US$207,281
2026-03-09 2026-03-09 PrS Proposed sale
NATHAN DOWDEN

Officer

Officer
15,010
12.58
US$188,826 		15,010 12.58 US$188,826
2026-03-06 2026-03-04 PlS Planned sale
3.4
WENTWORTH KORY JAMES

Chief Financial Officer

Officer
7,988 -5.5%
12.25
US$97,892 		7,988 -5.5% 12.25 US$97,892
2026-03-04 2026-03-04 PrS Proposed sale
3.4
KORY WENTWORTH

Officer

Officer
7,988
11.85
US$94,658 		7,988 11.85 US$94,658
2025-11-24 2025-11-21 PlS Planned sale
3.4
WENTWORTH KORY JAMES

Chief Financial Officer

Officer
8,910 -7.5%
9.98
US$88,932 		8,910 -7.5% 9.98 US$88,932
2025-11-21 2025-11-21 PrS Proposed sale
3.4
KORY WENTWORTH

Officer

Officer
8,910
9.17
US$81,705 		8,910 9.17 US$81,705
2025-11-24 2025-11-20 B Purchase
3.4
BAKER BROS. ADVISORS LP
Large shareholder
13,082 +0.3%
9.07
US$118,690 		13,082 +0.3% 9.07 US$118,690
2025-11-24 2025-11-20 B Purchase
3.4
BAKER BROS. ADVISORS LP
Large shareholder
1,186 +0.3%
9.07
US$10,760 		1,186 +0.3% 9.07 US$10,760
2025-11-24 2025-11-20 B Purchase
3.4
BAKER BROS. ADVISORS LP
Large shareholder
13,386 +0.3%
9.07
US$121,395 		13,386 +0.3% 9.07 US$121,395
2025-11-24 2025-11-20 B Purchase
3.4
BAKER BROS. ADVISORS LP
Large shareholder
1,213 +0.3%
9.07
US$11,000 		1,213 +0.3% 9.07 US$11,000
2025-11-18 2025-11-14 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
200,000 -6.3%
8.80
US$1,760,000 		200,000 -6.3% 8.80 US$1,760,000
2025-11-18 2025-11-14 S Sale
4.0
PARMAR KUSH
Non-Executive Director Large shareholder
200,000 -6.3%
8.80
US$1,760,000 		200,000 -6.3% 8.80 US$1,760,000
2025-11-14 2025-11-14 PrS Proposed sale
3.5
5AM Ventures V, L.P.

Affiliated Stockholder

Large shareholder
200,000
8.80
US$1,760,664 		200,000 8.80 US$1,760,664
2025-11-12 2025-11-12 B Purchase
3.4
BAKER BROS. ADVISORS LP
Large shareholder
11,494 +0.2%
7.95
US$91,431 		11,494 +0.2% 7.95 US$91,431
2025-11-12 2025-11-12 B Purchase
3.4
BAKER BROS. ADVISORS LP
Large shareholder
1,040 +0.3%
7.95
US$8,273 		1,040 +0.3% 7.95 US$8,273
2025-11-12 2025-11-12 B Purchase
3.4
BAKER BROS. ADVISORS LP
Large shareholder
80,881 +1.8%
7.73
US$625,331 		80,881 +1.8% 7.73 US$625,331
2025-11-12 2025-11-12 B Purchase
3.4
BAKER BROS. ADVISORS LP
Large shareholder
7,321 +2.0%
7.73
US$56,602 		7,321 +2.0% 7.73 US$56,602
2025-11-12 2025-11-11 B Purchase
3.4
BAKER BROS. ADVISORS LP
Large shareholder
30,879 +0.7%
7.54
US$232,812 		30,879 +0.7% 7.54 US$232,812
2025-11-12 2025-11-11 B Purchase
3.4
BAKER BROS. ADVISORS LP
Large shareholder
2,795 +0.8%
7.54
US$21,073 		2,795 +0.8% 7.54 US$21,073
2025-11-12 2025-11-11 B Purchase
3.4
BAKER BROS. ADVISORS LP
Large shareholder
11,701 +0.3%
7.39
US$86,481 		11,701 +0.3% 7.39 US$86,481
2025-11-12 2025-11-11 B Purchase
3.4
BAKER BROS. ADVISORS LP
Large shareholder
1,059 +0.3%
7.39
US$7,827 		1,059 +0.3% 7.39 US$7,827
2025-11-12 2025-11-10 B Purchase
3.4
BAKER BROS. ADVISORS LP
Large shareholder
2,947 +0.1%
7.22
US$21,290 		2,947 +0.1% 7.22 US$21,290
2025-11-12 2025-11-10 B Purchase
3.4
BAKER BROS. ADVISORS LP
Large shareholder
267 +0.1%
7.22
US$1,929 		267 +0.1% 7.22 US$1,929
2025-11-12 2025-11-10 B Purchase
3.4
BAKER BROS. ADVISORS LP
Large shareholder
25,364 +0.6%
7.21
US$182,973 		25,364 +0.6% 7.21 US$182,973
2025-11-12 2025-11-10 B Purchase
3.4
BAKER BROS. ADVISORS LP
Large shareholder
2,296 +0.6%
7.21
US$16,563 		2,296 +0.6% 7.21 US$16,563
2025-07-11 2025-07-09 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
6,935 -0.6%
7.50
US$52,026 		6,935 -0.6% 7.50 US$52,026
2025-07-11 2025-07-09 S Sale
3.5
5AM Ventures V, L.P.
Large shareholder
20,065 -0.6%
7.50
US$150,528 		20,065 -0.6% 7.50 US$150,528
2025-07-11 2025-07-09 S Sale
4.0
PARMAR KUSH
Non-Executive Director Large shareholder
6,935 -0.6%
7.50
US$52,026 		6,935 -0.6% 7.50 US$52,026
Explore more

More insider trading research around Entrada Therapeutics, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America